Literature DB >> 17251020

Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor.

Joanne Cleary1, Kathryn M Johnson, Anthony W Opipari, Gary D Glick.   

Abstract

Although PK11195 binds to the peripheral benzodiazepine receptor with nanomolar affinity, significant data exist which suggest that it has another cellular target distinct from the PBR. Here we demonstrate that PK11195 inhibits F(1)F(0)-ATPase activity in an OSCP-dependent manner, similar to the pro-apoptotic benzodiazepine Bz-423. Importantly, our data indicate that cellular responses observed with micromolar concentrations of PK11195, which are commonly attributed to modulation of the PBR, are likely a direct result of mitochondrial F(1)F(0)-ATPase inhibition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251020     DOI: 10.1016/j.bmcl.2006.12.102

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

Review 1.  Positron emission tomography imaging of neuroinflammation.

Authors:  Annachiara Cagnin; Michael Kassiou; Steve R Meikle; Richard B Banati
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.

Authors:  Michelle Sexton; Grace Woodruff; Eiron Cudaback; Faith R Kreitzer; Cong Xu; Yi Hsing Lin; Thomas Möller; Mingfeng Bai; H Charles Manning; Darryl Bornhop; Nephi Stella
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

Review 3.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

Review 4.  The changing landscape in translocator protein (TSPO) function.

Authors:  Vimal Selvaraj; Douglas M Stocco
Journal:  Trends Endocrinol Metab       Date:  2015-03-21       Impact factor: 12.015

5.  A unified structural model of the mammalian translocator protein (TSPO).

Authors:  Yan Xia; Kaitlyn Ledwitch; Georg Kuenze; Amanda Duran; Jun Li; Charles R Sanders; Charles Manning; Jens Meiler
Journal:  J Biomol NMR       Date:  2019-06-26       Impact factor: 2.835

Review 6.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 7.  OSCP subunit of mitochondrial ATP synthase: role in regulation of enzyme function and of its transition to a pore.

Authors:  Valentina Giorgio; Federico Fogolari; Giovanna Lippe; Paolo Bernardi
Journal:  Br J Pharmacol       Date:  2018-11-28       Impact factor: 8.739

Review 8.  From ATP to PTP and Back: A Dual Function for the Mitochondrial ATP Synthase.

Authors:  Paolo Bernardi; Fabio Di Lisa; Federico Fogolari; Giovanna Lippe
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 9.  The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology.

Authors:  Paolo Bernardi; Andrea Rasola; Michael Forte; Giovanna Lippe
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

10.  Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).

Authors:  Justina Šileikytė; Elizabeth Blachly-Dyson; Randall Sewell; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Fernanda Ricchelli; Paolo Bernardi; Michael Forte
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.